zzso chronic supplementation with zzso A zzso zzso has been approved as a treatment modality for zzso zzso The aim of the current study was to investigate the feasibility of home therapy for zzso disease during a zzso of zzso years and to make a proposal for practice zzso 

Based on experience in previous clinical zzso an algorithm for home treatment eligibility was zzso The number of successful and uneventful infusions was zzso as well as adverse and zzso zzso The presence and zzso of recombinant human zzso A antibodies were monitored every 3 zzso 

Thirty of the 36 patients eligible for home treatment received a total of zzso infusions at home zzso 44 zzso range zzso between March 2001 and July zzso Mean age was zzso years zzso Seventeen patients receiving home treatment zzso were zzso The majority of patients zzso out of zzso zzso undergoing home treatment received zzso zzso zzso alpha or zzso Six male patients developed an zzso zzso of which three developed these at zzso All patients with an zzso event were zzso A IgG positive at 3 zzso but three patients with zzso A antibodies did not develop side zzso Antibody titres between these patients did not zzso None of the events was zzso or necessitated urgent zzso 

zzso treatment with zzso A for zzso disease with zzso zzso for males and both zzso and zzso zzso for females is feasible and zzso and reduces both the burden related to chronic intravenous therapy and health care zzso Whether this can also be applied for male patients treated with zzso zzso has not yet been zzso 
